Site Search
Site Search
Displaying results 801 - 810 of 893
Info Session: funding opportunities with the Innovative Medicines Initiative
On 28 June 2013, IMI held an info session in Barcelona, Spain on its forthcoming funding opportunities in collaborative research and innovation. The session gathered over 100 scientists, researchers and SME representatives interested learning more about IMI’s future Calls for ...
22nd Edition – March 2013
Table of contents:
- IMI Stakeholder Forum 2013 - Nobel Prize winner confirmed as speaker
- Flu vaccines subject of new indicative IMI Call topic
- Lively discussions at joint IMI – C-Path event
- IMI’s personalised medicine projects in the spotlight in Dublin
- Thomson Reuters report highlights impact of IMI projects
- UK Chief Medical Officer points to IMI in major antibiotic resistance report
- European Journal of Immunology puts IMI projects in the spotlight
- News from the projects
IMI Stakeholder Forum 2013
IMI Stakeholder Forum 2013 Public-private partnerships for health research and innovation More than 250 people attended IMI’s annual Stakeholder Forum in Brussels, Belgium on 13 May and many more followed the live webcast. The morning of the event was dedicated to brain research ...
21st Edition - February 2013
Table of contents:
- €196 million European Lead Factory project gets underway
- First antimicrobial resistance projects officially launched
- Sign up for the joint IMI – C-Path event on 7 March
- Join IMI in Dublin for a workshop on personalised medicine
- IMI Stakeholder Forum 2013 – save the date!
- Independent experts: IMI ‘should be continued with enlarged scope’
- 8th Call for proposals – countdown to the deadline!
- IMI in the news
- News from the projects
IMI and personalised medicine
Over 70 people attended IMI’s workshop entitled Applying open innovation to bring personalised medicine to new disease areas on the afternoon of 20 March in Dublin, Ireland . The IMI workshop featured presentations demonstrating how IMI projects are working on personalised ...
Collaborating for Cures
Leveraging Global Public-Private Partnerships (PPPs) to Accelerate Biopharmaceuticals Development IMI and the Critical Path Institute (C-Path) held a joint event on the challenges and opportunities of public-private partnerships (PPPs) on 7 March 2013, at the Sheraton Hotel ...
COMBACTE-NET
Combatting Bacterial Resistance in Europe
TRANSLOCATION
Molecular basis of the bacterial cell wall permeability